Investigation of the formation of drug-drug cocrystals and coamorphous systems of the antidiabetic drug gliclazide
Open Access
- 1 April 2019
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 561, 35-42
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland (12/RC/2275)
- SSPC
- Royal Embassy of Saudi Arabia
This publication has 30 references indexed in Scilit:
- Molecular Dynamics, Physical Stability and Solubility Advantage from Amorphous Indapamide DrugMolecular Pharmaceutics, 2013
- Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Physicochemical Investigations and Stability Studies of Amorphous GliclazideAAPS PharmSciTech, 2012
- Solid state investigation and characterization of the polymorphic and pseudopolymorphic forms of indapamideJournal of Pharmaceutical and Biomedical Analysis, 2010
- Physicochemical Properties of Solid Dispersions of Gliclazide in Polyvinylpyrrolidone K90AAPS PharmSciTech, 2009
- Dissolution enhancement of gliclazide using in situ micronization by solvent change methodPowder Technology, 2008
- Enhancement of Dissolution Rate of Gliclazide Using Solid Dispersions with Polyethylene Glycol 6000AAPS PharmSciTech, 2008
- Uncertainty evaluation of humidity sensors calibrated by saturated salt solutionsMeasurement, 2007
- Preparation and In Vitro/In Vivo Evaluation of Gliclazide Loaded Eudragit Nanoparticles as a Sustained Release CarriersDrug Development and Industrial Pharmacy, 2007
- Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrinPharmaceutica Acta Helvetiae, 2000